Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer

NCT00288444 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Lung Cancer
Soft Tissue Sarcoma
Colorectal Carcinoma
Breast Cancer
Prostate Cancer

Interventions

DRUG: Lonafarnib
DRUG: Docetaxel

Sponsor

Emory University

Collaborators

[object Object]
[object Object]